HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free All Versions of this Article: 100/6/1770    most recent 01288.2005v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Supinski, G. S. Articles by Callahan, L. A. Search for Related Content PubMed PubMed Citation Articles by Supinski, G. S. Articles by Callahan, L. A.

Caspase activation contributes to endotoxin-induced diaphragm weakness

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Medical College of Georgia, Augusta, Georgia

Submitted 6 October 2005 ; accepted in final form 6 January 2006

Infections produce significant respiratory muscle weakness, but the mechanisms by which inflammation reduces muscle force remain incompletely understood. Recent work suggests that caspase 3 releases actin and myosin from the contractile protein lattice, so we postulated that infections may reduce skeletal muscle force by activating caspase 3. The present experiments were designed to test this hypothesis by determining 1) diaphragm caspase 3 activation in the diaphragm after endotoxin and 2) the effect of a broad-spectrum caspase inhibitor, Z-Val-Ala-Asp(OCH₃)-fluoromethylketone (zVAD-fmk), and a selective caspase 3 inhibitor, N-acetyl-Asp-Glu-Val-Asp-al (DEVD-CHO), on endotoxin-induced diaphragm weakness. Caspase 3 activation was assessed by measuring caspase protein levels and by measuring cleavage of a fluorogenic substrate. Diaphragm force was measured in response to electrical stimulation (1–150 Hz). Caspase-mediated spectrin degradation was assessed by Western blotting. Parameters were compared in mice given saline, endotoxin (12 mg/kg ip), endotoxin plus zVAD-fmk (3 mg/kg iv), zVAD-fmk alone, or endotoxin plus DEVD-CHO (3 mg/kg iv). Endotoxin increased diaphragm active caspase 3 protein (P < 0.003), increased caspase 3 activity (P < 0.002), increased diaphragm spectrin degradation (P < 0.001), and reduced diaphragm force (P < 0.001). Administration of zVAD-fmk or DEVD-CHO prevented endotoxin-induced weakness (e.g., force in response to 150-Hz stimulation was 23.8 ± 1.4, 12.1 ± 1.3, 23.5 ± 0.8, 22.7 ± 1.3, and 24.4 ± 0.8 N/cm², respectively, for control, endotoxin, endotoxin plus zVAD-fmk, endotoxin plus DEVD-CHO, and zVAD-fmk alone treated groups, P < 0.001). Caspase inhibitors also prevented spectrin degradation. In conclusion, endotoxin administration elicits significant diaphragm caspase 3 activation and caspase-mediated diaphragmatic weakness.

sepsis; zVAD-fmk; caspase 3 activity; diaphragm specific force; spectrin degradation products

This article has been cited by other articles:

				K. A. Huey, R. R. Roy, H. Zhong, and C. Lullo Time-dependent changes in caspase-3 activity and heat shock protein 25 after spinal cord transection in adult rats Exp Physiol, March 1, 2008; 93(3): 415 - 425. [Abstract] [Full Text] [PDF]

				B. A. Valentine and C. V. Lohr Myonecrosis in three horses with colic: evidence for endotoxic injury Vet Rec., December 8, 2007; 161(23): 786 - 789. [Abstract] [Full Text] [PDF]

				J. M. McClung, A. N. Kavazis, M. A. Whidden, K. C. DeRuisseau, D. J. Falk, D. S. Criswell, and S. K. Powers Antioxidant administration attenuates mechanical ventilation-induced rat diaphragm muscle atrophy independent of protein kinase B (PKB Akt) signalling J. Physiol., November 15, 2007; 585(1): 203 - 215. [Abstract] [Full Text] [PDF]

				H. Degens, A. K. Swisher, Y. F. Heijdra, P. M. Siu, P. N. Richard Dekhuijzen, and S. E. Alway Apoptosis and Id2 expression in diaphragm and soleus muscle from the emphysematous hamster Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R135 - R144. [Abstract] [Full Text] [PDF]

				H. W. H. van Hees, H. F. M. van der Heijden, C. A. C. Ottenheijm, L. M. A. Heunks, C. J. C. Pigmans, F. W. A. Verheugt, R. M. H. J. Brouwer, and P. N. R. Dekhuijzen Diaphragm single-fiber weakness and loss of myosin in congestive heart failure rats Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H819 - H828. [Abstract] [Full Text] [PDF]

				G. S. Supinski and L. A. Callahan Free radical-mediated skeletal muscle dysfunction in inflammatory conditions J Appl Physiol, May 1, 2007; 102(5): 2056 - 2063. [Abstract] [Full Text] [PDF]

				G. S. Supinski, X. Ji, W. Wang, and L. A. Callahan The extrinsic caspase pathway modulates endotoxin-induced diaphragm contractile dysfunction J Appl Physiol, April 1, 2007; 102(4): 1649 - 1657. [Abstract] [Full Text] [PDF]

				E. E. Dupont-Versteegden, B. A. Strotman, C. M. Gurley, D. Gaddy, M. Knox, J. D. Fluckey, and C. A. Peterson Nuclear translocation of EndoG at the initiation of disuse muscle atrophy and apoptosis is specific to myonuclei Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1730 - R1740. [Abstract] [Full Text] [PDF]

				C. A. C. Ottenheijm, L. M. A. Heunks, Y.-P. Li, B. Jin, R. Minnaard, H. W. H. van Hees, and P. N. R. Dekhuijzen Activation of the Ubiquitin-Proteasome Pathway in the Diaphragm in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 1, 2006; 174(9): 997 - 1002. [Abstract] [Full Text] [PDF]

				M. B. Reid Waste not, weak not? J Appl Physiol, June 1, 2006; 100(6): 1753 - 1754. [Full Text] [PDF]